Haffkine Ajintha Pharmaceuticals Limited - Company Profile

It is a pharma public limited state government company based in Mumbai, Maharashtra, India, established in 1977.
1977 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Haffkine Ajintha Pharmaceuticals Limited

Haffkine Ajintha Pharmaceuticals Limited, a active public limited state government company, was established on 22 April 1977 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH1977SGC019615. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹1.77 M.

It upholds a compliant status. Its leadership includes Subhash Venkatrao Shankarwar (Nominee Director), Madhavi Suresh Chaware (Managing Director), Sunil Balajirao Mahindrakar (Managing Director). Past directors included Prakash Ranganath Sabade, Anup Kumar Yadav, Rajesh Bhagwatrao Deshmukh. It holds no open charges and ₹7.01 Cr settled loans. Its latest AGM occurred on 29 December 2023, with the balance sheet filed on 31 March 2023. It is based at Haffkine Institute Compoundacharya Donde Marg Parel, Mumbai, Maharashtra, 400012.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH1977SGC019615

  • Registration Number

    019615

  • Incorporation Date

    22 April 1977

  • Authorized Capital

    ₹3.00 M

  • Paid-Up Capital

    ₹1.77 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 M
  • Paid Up Capital ₹ 1.77 M
  • Company Age 48 Year, 10 Months
  • Last Filing with ROC 31 Mar 2023
  • Satisfied Charges ₹ 7.01 Cr
  • Revenue Growth **** 213.98%
  • Profit Growth **** 92.32%
  • Ebitda **** 89.41%
  • Net Worth -0.63%
  • Total Assets **** 46.19%
Company report

Haffkine Ajintha Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Haffkine Ajintha Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Haffkine Ajintha Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Subhash Venkatrao Shankarwar Nominee Director 26 Mar 2015 Current
Madhavi Suresh Chaware Managing Director 08 Feb 2022 Current
Sunil Balajirao Mahindrakar Managing Director 18 Jul 2025 Current
Pradeep Dharam Dhivar Director 09 Sep 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 29 Jan 2013 Past
Pramod Abcsdd Managing Director 17 Jun 2019 Past
Pramod Abcsdd Managing Director 20 Aug 2020 Past
Pramod Abcsdd Managing Director 08 Feb 2022 Past
Pramod Abcsdd Managing Director 27 Nov 2020 Past
Pramod Abcsdd Managing Director 05 Jan 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Haffkine Ajintha Pharmaceuticals.

Haffkine Ajintha Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 213.98% increase. The company also saw a substantial improvement in profitability, with a 92.32% increase in profit. The company's net worth dipped by a decrease of 0.63%.

Haffkine Ajintha Pharmaceuticals revenue growth over time
Haffkine Ajintha Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 213.98%
*******
*******
*******
*******
Revenue from Operations
*******
 195.90%
*******
*******
*******
*******
Total Assets
*******
 46.19%
*******
*******
*******
*******
Profit or Loss
*******
 92.32%
*******
*******
*******
*******
Net Worth
*******
 -0.63%
*******
*******
*******
*******
EBITDA
*******
 89.41%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Haffkine Ajintha Pharmaceuticals?

In 2023, Haffkine Ajintha Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹70,050,000.00

Charges Breakdown by Lending Institutions
  • The United Western Bank Ltd : 7.01 Cr
Latest Charge Details
Date Lender Amount Status
05 Jan 1998 The United Western Bank Ltd ₹1.50 Cr Satisfied
01 Oct 1991 The United Western Bank Ltd ₹3.00 M Satisfied
31 Jul 1990 The United Western Bank Ltd ₹2.30 M Satisfied
23 May 1985 The United Western Bank Ltd ₹4.35 Cr Satisfied
15 Dec 1979 The United Western Bank Ltd ₹0.30 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Haffkine Ajintha Pharmaceuticals?

Unlock and access historical data on people associated with Haffkine Ajintha Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Haffkine Ajintha Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Haffkine Ajintha Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Haffkine Ajintha Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Pradeep Dharam Dhivar was appointed as a Director was appointed as a Director on 09 Sep 2025 & has been associated with this company since 5 months 18 days . was documented.

  • Director Appointment

    Progress on Sunil Balajirao Mahindrakar was appointed as a Managing Director was appointed as a Managing Director on 18 Jul 2025 & has been associated with this company since 7 months 10 days . was documented.

  • Annual General Meeting

    Haffkine Ajintha Pharmaceuticals Limited last Annual general meeting of members was held on 29 Dec 2023 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Haffkine Ajintha Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was documented.

  • Charges

    A charge registered on 01 Oct 1991 via Charge ID 90187544 with The United Western Bank Ltd was fully satisfied on 11 Oct 2022. was recorded as a recent event.

  • Charges

    A charge registered on 31 Jul 1990 via Charge ID 90187516 with The United Western Bank Ltd was fully satisfied on 11 Oct 2022. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Haffkine Ajintha Pharmaceuticals Limited?

The CIN of Haffkine Ajintha Pharmaceuticals Limited is U24239MH1977SGC019615.

Where is Haffkine Ajintha Pharmaceuticals Limited headquartered?

Haffkine Ajintha Pharmaceuticals Limited is headquartered at Haffkine Institute Compoundacharya Donde Marg Parel, Mumbai, Maharashtra, 400012.

When was Haffkine Ajintha Pharmaceuticals Limited incorporated?

Haffkine Ajintha Pharmaceuticals Limited was incorporated on 22 April 1977.

Who are the current directors of Haffkine Ajintha Pharmaceuticals Limited?

The current directors of Haffkine Ajintha Pharmaceuticals Limited are

What is the primary industry of Haffkine Ajintha Pharmaceuticals Limited?

The primary industry of Haffkine Ajintha Pharmaceuticals Limited is Manufacturing.

Is Haffkine Ajintha Pharmaceuticals Limited a listed company?

Haffkine Ajintha Pharmaceuticals Limited is unlisted.

What is the capital structure of Haffkine Ajintha Pharmaceuticals Limited?

The authorized capital of Haffkine Ajintha Pharmaceuticals Limited is ₹3.00 M, and the paid-up capital is ₹1.77 M.

What is the compliance status of Haffkine Ajintha Pharmaceuticals Limited?

The compliance status of Haffkine Ajintha Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available